VERIGRAFT makes transplantation possible without the severe risks of immunosuppression, and uses regenerative medicine technology to address so far incurable diseases.

Our personalized tissue-engineered transplants that do not necessitate immunosuppression.

Fully biological transplants that can surpass synthetic grafts with regards to durability and resistance to infection.

Preclinical development for our personalized tissue-engineered veins (P-TEV) is completed and successful clinical proof of concept exists. Ready to start clinical trials.